ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 727,31
-0,26%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Alder BioPharmaceuticals Inc (ALDR)

  7. Alder BioPharmaceuticals Inc (ALDR) Actualités

ALDR

Alder BioPharmaceuticals (ALDR)

Alder BioPharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALDR
DateHeureSourceTitreSymboleSociété
13/02/202022h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
01/11/201916h45Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ALDRAlder BioPharmaceuticals Inc
31/10/201921h28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ALDRAlder BioPharmaceuticals Inc
25/10/201912h10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
25/10/201901h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201923h33Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201923h13Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915h26Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915h15Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915h04Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201915h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALDRAlder BioPharmaceuticals Inc
11/10/201914h00GlobeNewswire Inc.Lundbeck and Alder BioPharmaceuticals announce updated information in the tender offer materials filed with SECNASDAQ:ALDRAlder BioPharmaceuticals Inc
10/10/201918h12Edgar (US Regulatory)Schedule 13gNASDAQ:ALDRAlder BioPharmaceuticals Inc
10/10/201914h01GlobeNewswire Inc.Alder BioPharmaceuticals® Announces First-in-Human Dosing in Phase 1 ALD1910 Study for Preventive Treatment of MigraineNASDAQ:ALDRAlder BioPharmaceuticals Inc
26/09/201920h18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALDRAlder BioPharmaceuticals Inc
26/09/201919h26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ALDRAlder BioPharmaceuticals Inc
23/09/201922h08Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ALDRAlder BioPharmaceuticals Inc
23/09/201921h25Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ALDRAlder BioPharmaceuticals Inc
18/09/201922h51Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ALDRAlder BioPharmaceuticals Inc
18/09/201900h14PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201923h15Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201917h09PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Alder BioPharmaceuticals has obtained a Fair Price in its sale ...NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201913h46PR Newswire (US)Alder (ALDR) Alert: Johnson Fistel Investigates Proposed Sale of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting a F...NASDAQ:ALDRAlder BioPharmaceuticals Inc
05/09/201922h01GlobeNewswire Inc.Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache...NASDAQ:ALDRAlder BioPharmaceuticals Inc
04/09/201915h00PR Newswire (US)Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman as CEO to Lead the Next Phase of GrowthNASDAQ:ALDRAlder BioPharmaceuticals Inc
30/08/201922h01GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
28/08/201922h01GlobeNewswire Inc.Alder BioPharmaceuticals® to Present at Two Upcoming September Investor ConferencesNASDAQ:ALDRAlder BioPharmaceuticals Inc
06/08/201922h07GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating ResultsNASDAQ:ALDRAlder BioPharmaceuticals Inc
06/08/201922h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALDRAlder BioPharmaceuticals Inc
02/08/201922h01GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ALDR

Dernières Valeurs Consultées

EU
PX1
CAC 40
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
EU
BEL20
Bel 20
NYSE
MCD
McDonalds
EU
EN
Bouygues
EU
CAP
Capgemini
EU
SGO
Cie de SaintGobain
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
EU
GLE
Societe Generale
EU
ACA
Credit Agricole
EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés